Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
38
HNSBF Quote, Financials, Valuation and Earnings
Last price:
$3.00
Seasonality move
:
10.81%
Day range:
$3.00 - $3.00
52-week range:
$2.65 - $3.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.81x
P/B ratio:
--
Volume:
--
Avg. volume:
180
1-year change:
13.21%
Market cap:
$196.8M
Revenue:
$12.7M
EPS (TTM):
-$1.08
Earnings Data
Next earnings date for HNSBF
Feb 06
2025
Most recent earnings per share
-$0.15
Missed by $0.15
(Oct 17/2024)
Consensus Estimate
--
(Oct 17/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HNSBF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/17/2024 | Q3 | -- | $4.7M | -$0.15 | -- | -- |
| 07/18/2024 | Q2 | -- | $3.2M | -$0.31 | -- | -- |
| 04/18/2024 | Q1 | -- | $5.4M | -$0.40 | -- | -- |
| 02/02/2024 | Q4 | -- | $4.7M | -$0.22 | -- | -- |
| 10/26/2023 | Q3 | -- | $2.1M | -$0.44 | -- | -- |
| 07/20/2023 | Q2 | -- | $3.5M | -$0.46 | -- | -- |
| 04/20/2023 | Q1 | -- | $2.3M | -$0.38 | -- | -- |
| 02/02/2023 | Q4 | -- | $2.9M | -$0.30 | -- | -- |
| 10/20/2022 | Q3 | -- | $6.4M | -$0.33 | -- | -- |
| 07/19/2022 | Q2 | -- | $2.7M | -$0.39 | -- | -- |
| 04/21/2022 | Q1 | -- | $3.3M | -$0.33 | -- | -- |
| 02/03/2022 | Q4 | -- | $1.7M | -$0.42 | -- | -- |
| 10/21/2021 | Q3 | -- | $572.7K | -$0.39 | -- | -- |
| 06/30/2021 | Q2 | -- | $539.5K | -$0.35 | -- | -- |
| 03/31/2021 | Q1 | -- | $1.1M | -$0.28 | -- | -- |
| 12/31/2020 | Q4 | -- | $445.2K | -$0.28 | -- | -- |
| 09/30/2020 | Q3 | -- | $86.1K | -$0.31 | -- | -- |
| 06/30/2020 | Q2 | -- | $64.5K | -$0.26 | -- | -- |
| 03/31/2020 | Q1 | -- | $92K | -$0.24 | -- | -- |
| 12/31/2019 | Q4 | -- | $125.3K | -$0.29 | -- | -- |
| 09/30/2019 | Q3 | -- | $68K | -$0.25 | -- | -- |
| 06/30/2019 | Q2 | -- | $62.7K | -$0.22 | -- | -- |
| 03/31/2019 | Q1 | -- | $100.1K | -$0.20 | -- | -- |
| 12/31/2018 | Q4 | -- | $153.2K | -$0.23 | -- | -- |
| 09/30/2018 | Q3 | -- | $54.1K | -$0.18 | -- | -- |
| 06/30/2018 | Q2 | -- | $104K | -$0.18 | -- | -- |
| 03/31/2018 | Q1 | -- | $72.6K | -$0.15 | -- | -- |
| 12/31/2017 | Q4 | -- | $121.7K | -$0.16 | -- | -- |
| 09/30/2017 | Q3 | -- | $83.4K | -$0.13 | -- | -- |
| 06/30/2017 | Q2 | -- | $78.7K | -$0.15 | -- | -- |
| 03/31/2017 | Q1 | -- | $118.6K | -$0.14 | -- | -- |
| 12/31/2016 | Q4 | -- | $60.1K | -$0.11 | -- | -- |
| 09/30/2016 | Q3 | -- | $106.5K | -$0.10 | -- | -- |
| 06/30/2016 | Q2 | -- | $66K | -$0.11 | -- | -- |
| 03/31/2016 | Q1 | -- | $69.5K | -$0.07 | -- | -- |
| 12/31/2015 | Q4 | -- | $208.2K | -$0.07 | -- | -- |
| 09/30/2015 | Q3 | -- | $62.3K | -$0.05 | -- | -- |
| 06/30/2015 | Q2 | -- | $62.8K | -$0.08 | -- | -- |
| 03/31/2015 | Q1 | -- | $462.6K | -$0.05 | -- | -- |
Hansa Biopharma AB Earnings Questions
-
How Much did Hansa Biopharma AB Generate in Revenue Last Quarter?
Hansa Biopharma AB reported $4.7M worth of top line sales in its most recent quarter.
-
Did Hansa Biopharma AB Beat Earnings Last Quarter?
Hansa Biopharma AB announced earnings per share of -$0.15 which represents a miss of analyst forecast a -- per share.
-
Is Hansa Biopharma AB Profitable?
Hansa Biopharma AB reported $3.6M that represents $0.05 per share over the last quarter.
-
What is the Analyst Consensus for Hansa Biopharma AB EPS Next Year?
Hansa Biopharma AB's earnings are forecast to grow from -$1.50 per share to -- per share next year representing an increase of --.
-
When is Hansa Biopharma AB's Earnings Date?
Hansa Biopharma AB's next earnings date is February 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
